POINT BIOPHARMA GLOBAL INC. Contract Liability (Deferred Revenue)
POINT BIOPHARMA GLOBAL INC. had Contract Liability (Deferred Revenue) of $12.59 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2023-11-13
- 2023-09-30: Contract with Customer, Liability, Current $12.59M.
- 2023-06-30: Contract with Customer, Liability, Current $15.90M.
- 2023-03-31: Contract with Customer, Liability, Current $16.52M.
- 2022-12-31: Contract with Customer, Liability, Current $23.24M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2023-09-30 | $12.59M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $15.90M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $16.52M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $23.24M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-27 |